Kilitch Drugs(I) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

323.70

+5.60 (+1.76%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

323.70

+5.60 (+1.76%)
15:42 Dec 20

Quality

68/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

40/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	68.52	114.23	139.6	154.37	157.53
Operating Expenses +	63.33	103.86	122.03	130.22	140.43
Raw Material	36.22	65.48	74.53	79.08	84.88
Increase Decrease in Cost	1.09	-0.05	0.23	-0.12	-0.01
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	5.24	6.18	11.73	10.01	10.18
Miscellaneous Expenses	20.78	32.25	35.54	41.25	45.38
Operating Profit	5.19	10.37	17.57	24.15	17.1
Other Income	2.67	2.91	2.92	4.48	11.16
Depreciation	1.99	2.47	3.55	3.35	3.19
Interest	0.75	1.2	4.92	5.93	4.96
Profit before tax and exceptio..	5.12	9.61	12.01	19.35	20.11
Exceptional Items	0	0	0	0	0
PBT	5.12	9.61	12.01	19.35	20.11
Provision for Taxation	1.35	3.4	3.73	5.78	5.97
Net Profit	3.77	6.21	8.28	13.58	14.14
NET Profit after MI	3.67	7.37	10.45	14.6	16.46
EPS	2.37	4.73	6.71	9.17	10.28
Operating Profit Margin (%)	7.57	9.08	12.59	15.64	10.86
Net Profit Margin (%)	5.36	6.45	7.49	9.46	10.45

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	69.20	69.20	69.20	69.20	69.20
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	30.80	30.80	30.80	30.80	30.80
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00